VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K10. A total of 2 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $759,000 | -45.4% | 28,873 | +111.3% | 0.37% | -44.3% |
| Q4 2015 | $1,389,000 | +12.7% | 13,664 | +97.7% | 0.66% | +25.7% |
| Q3 2015 | $1,233,000 | -31.5% | 6,913 | -14.7% | 0.53% | -25.3% |
| Q2 2015 | $1,801,000 | +10.4% | 8,108 | -1.4% | 0.70% | +7.5% |
| Q1 2015 | $1,632,000 | +36.6% | 8,219 | -1.6% | 0.66% | +28.4% |
| Q4 2014 | $1,195,000 | +8.8% | 8,350 | -0.2% | 0.51% | +6.0% |
| Q3 2014 | $1,098,000 | +14.1% | 8,367 | +9.6% | 0.48% | +15.3% |
| Q2 2014 | $962,000 | -3.5% | 7,631 | +0.9% | 0.42% | -10.5% |
| Q1 2014 | $997,000 | +26.8% | 7,562 | +13.0% | 0.47% | +27.3% |
| Q4 2013 | $786,000 | +45.8% | 6,693 | +29.5% | 0.37% | +42.4% |
| Q3 2013 | $539,000 | +21.1% | 5,167 | 0.0% | 0.26% | +13.7% |
| Q2 2013 | $445,000 | – | 5,167 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOYD WATTERSON ASSET MANAGEMENT LLC/OH | 6,913 | $1,233,000 | 0.53% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 91,800 | $16,310,000 | 0.04% |